Figure 5From: Investigation of utilization of nanosuspension formulation to enhance exposure of 1,3-dicyclohexylurea in rats: Preparation for PK/PD study via subcutaneous route of nanosuspension drug delivery DCU SC PK plasma exposure. Thirty-milligram per kilogram nanosuspension versus regular suspension).Back to article page